Biotech breakthrough in virus vaccines
published : 12 Apr 2022 at 04:00
The National Centre for Genetic Engineering and Biotechnology (Biotec) recently announced the success of developing a pseudotyped virus for a Covid-19 vaccine and drug trials.
Anan Jongkaewwattana, director of the Veterinary Health Innovation and Management Research Group of Biotec, said researchers have successfully created an innocuous pseudotyped virus for all strains for the first time.
“It is made to imitate SARS-CoV-2, which uses its spike protein for binding and entering cells. Researchers have taken and inserted it into another harmless virus,” he said.
Anan Jongkaewwattana,…
